BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) Fundamental Analysis & Valuation

FRA:BRYN • US0846707026

Current stock price

416.85 EUR
-0.8 (-0.19%)
Last:

This BRYN.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. BRYN.DE Profitability Analysis

1.1 Basic Checks

  • BRYN had positive earnings in the past year.
  • BRYN had a positive operating cash flow in the past year.
  • BRYN had positive earnings in 4 of the past 5 years.
  • BRYN had a positive operating cash flow in each of the past 5 years.
BRYN.DE Yearly Net Income VS EBIT VS OCF VS FCFBRYN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B -20B 40B 60B 80B

1.2 Ratios

  • BRYN has a Return On Assets of 5.50%. This is amongst the best in the industry. BRYN outperforms 82.76% of its industry peers.
  • With a decent Return On Equity value of 9.66%, BRYN is doing good in the industry, outperforming 65.52% of the companies in the same industry.
  • BRYN has a Return On Invested Capital of 4.53%. This is in the better half of the industry: BRYN outperforms 63.79% of its industry peers.
  • BRYN had an Average Return On Invested Capital over the past 3 years of 4.13%. This is significantly below the industry average of 9.93%.
  • The last Return On Invested Capital (4.53%) for BRYN is above the 3 year average (4.13%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.5%
ROE 9.66%
ROIC 4.53%
ROA(3y)4.77%
ROA(5y)5.71%
ROE(3y)8.68%
ROE(5y)10.68%
ROIC(3y)4.13%
ROIC(5y)3.72%
BRYN.DE Yearly ROA, ROE, ROICBRYN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

  • BRYN's Profit Margin of 18.13% is fine compared to the rest of the industry. BRYN outperforms 74.14% of its industry peers.
  • In the last couple of years the Profit Margin of BRYN has declined.
  • With a Operating Margin value of 16.72%, BRYN perfoms like the industry average, outperforming 55.17% of the companies in the same industry.
  • In the last couple of years the Operating Margin of BRYN has grown nicely.
  • BRYN has a worse Gross Margin (17.71%) than 62.07% of its industry peers.
  • BRYN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 16.72%
PM (TTM) 18.13%
GM 17.71%
OM growth 3Y7.37%
OM growth 5Y4.91%
PM growth 3Y-9.72%
PM growth 5Y-5.61%
GM growth 3Y3.45%
GM growth 5Y2.09%
BRYN.DE Yearly Profit, Operating, Gross MarginsBRYN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. BRYN.DE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), BRYN is creating some value.
  • BRYN has less shares outstanding than it did 1 year ago.
  • BRYN has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for BRYN has been reduced compared to a year ago.
BRYN.DE Yearly Shares OutstandingBRYN.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M
BRYN.DE Yearly Total Debt VS Total AssetsBRYN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B 800B 1T

2.2 Solvency

  • Based on the Altman-Z score of 1.36, we must say that BRYN is in the distress zone and has some risk of bankruptcy.
  • BRYN has a Altman-Z score (1.36) which is in line with its industry peers.
  • BRYN has a debt to FCF ratio of 6.58. This is a slightly negative value and a sign of low solvency as BRYN would need 6.58 years to pay back of all of its debts.
  • BRYN has a Debt to FCF ratio of 6.58. This is in the better half of the industry: BRYN outperforms 60.34% of its industry peers.
  • BRYN has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
  • BRYN has a better Debt to Equity ratio (0.18) than 70.69% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 6.58
Altman-Z 1.36
ROIC/WACC1.41
WACC3.22%
BRYN.DE Yearly LT Debt VS Equity VS FCFBRYN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B

2.3 Liquidity

  • A Current Ratio of 1.33 indicates that BRYN should not have too much problems paying its short term obligations.
  • BRYN has a Current ratio (1.33) which is comparable to the rest of the industry.
  • BRYN has a Quick Ratio of 1.11. This is a normal value and indicates that BRYN is financially healthy and should not expect problems in meeting its short term obligations.
  • BRYN has a Quick ratio (1.11) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.33
Quick Ratio 1.11
BRYN.DE Yearly Current Assets VS Current LiabilitesBRYN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. BRYN.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 17.97% over the past year.
  • Measured over the past years, BRYN shows a quite strong growth in Earnings Per Share. The EPS has been growing by 17.78% on average per year.
  • The Revenue has been growing slightly by 0.60% in the past year.
  • Measured over the past years, BRYN shows a small growth in Revenue. The Revenue has been growing by 7.84% on average per year.
EPS 1Y (TTM)17.97%
EPS 3Y21.97%
EPS 5Y17.78%
EPS Q2Q%33.51%
Revenue 1Y (TTM)0.6%
Revenue growth 3Y10.38%
Revenue growth 5Y7.84%
Sales Q2Q%2.13%

3.2 Future

  • The Earnings Per Share is expected to grow by 2.26% on average over the next years.
  • BRYN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.89% yearly.
EPS Next Y-0.33%
EPS Next 2Y0.31%
EPS Next 3Y1.09%
EPS Next 5Y2.26%
Revenue Next Year0.8%
Revenue Next 2Y0.19%
Revenue Next 3Y1.32%
Revenue Next 5Y4.89%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BRYN.DE Yearly Revenue VS EstimatesBRYN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 100B 200B 300B 400B
BRYN.DE Yearly EPS VS EstimatesBRYN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10K 20K 30K

More info and screens

Find the best growth stocksShow best growing peers

8

4. BRYN.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 0.01 indicates a rather cheap valuation of BRYN.
  • Based on the Price/Earnings ratio, BRYN is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
  • BRYN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.23.
  • With a Price/Forward Earnings ratio of 0.01, the valuation of BRYN can be described as very cheap.
  • 98.28% of the companies in the same industry are more expensive than BRYN, based on the Price/Forward Earnings ratio.
  • BRYN is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.28, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 0.01
Fwd PE 0.01
BRYN.DE Price Earnings VS Forward Price EarningsBRYN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • BRYN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. BRYN is cheaper than 94.83% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, BRYN is valued cheaply inside the industry as 98.28% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 0.04
EV/EBITDA 0.64
BRYN.DE Per share dataBRYN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 100K 200K 300K 400K

4.3 Compensation for Growth

  • The decent profitability rating of BRYN may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0
EPS Next 2Y0.31%
EPS Next 3Y1.09%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BRYN.DE Dividend Analysis

5.1 Amount

  • No dividends for BRYN!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BRYN.DE Fundamentals: All Metrics, Ratios and Statistics

BERKSHIRE HATHAWAY INC-CL B

FRA:BRYN (3/20/2026, 5:27:52 PM)

416.85

-0.8 (-0.19%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)02-28
Earnings (Next)05-01
Inst Owners26.93%
Inst Owner ChangeN/A
Ins Owners37.74%
Ins Owner ChangeN/A
Market Cap600.26M
Revenue(TTM)372.13B
Net Income(TTM)67.46B
Analysts44
Price Target442.96 (6.26%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.5%
Min EPS beat(2)0.19%
Max EPS beat(2)4.81%
EPS beat(4)3
Avg EPS beat(4)9.5%
Min EPS beat(4)-9.78%
Max EPS beat(4)42.8%
EPS beat(8)6
Avg EPS beat(8)8.01%
EPS beat(12)8
Avg EPS beat(12)5.87%
EPS beat(16)12
Avg EPS beat(16)8.15%
Revenue beat(2)1
Avg Revenue beat(2)-0.81%
Min Revenue beat(2)-2.33%
Max Revenue beat(2)0.72%
Revenue beat(4)1
Avg Revenue beat(4)-1.43%
Min Revenue beat(4)-4.09%
Max Revenue beat(4)0.72%
Revenue beat(8)3
Avg Revenue beat(8)-1.35%
Revenue beat(12)5
Avg Revenue beat(12)-0.47%
Revenue beat(16)6
Avg Revenue beat(16)-0.84%
PT rev (1m)0.43%
PT rev (3m)-1.07%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.66%
EPS NY rev (1m)0%
EPS NY rev (3m)0.12%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 0.01
Fwd PE 0.01
P/S 0
P/FCF 0.04
P/OCF 0.02
P/B 0
P/tB 0
EV/EBITDA 0.64
EPS(TTM)29542.35
EY7087.05%
EPS(NY)28895.49
Fwd EY6931.87%
FCF(TTM)11681.5
FCFY2802.33%
OCF(TTM)23813.8
OCFY5712.8%
SpS224930.13
BVpS421994.83
TBVpS349677
PEG (NY)N/A
PEG (5Y)0
Graham Number529624
Profitability
Industry RankSector Rank
ROA 5.5%
ROE 9.66%
ROCE 5.61%
ROIC 4.53%
ROICexc 4.87%
ROICexgc 5.82%
OM 16.72%
PM (TTM) 18.13%
GM 17.71%
FCFM 5.19%
ROA(3y)4.77%
ROA(5y)5.71%
ROE(3y)8.68%
ROE(5y)10.68%
ROIC(3y)4.13%
ROIC(5y)3.72%
ROICexc(3y)4.31%
ROICexc(5y)3.94%
ROICexgc(3y)5.19%
ROICexgc(5y)4.78%
ROCE(3y)5.11%
ROCE(5y)4.61%
ROICexgc growth 3Y9.15%
ROICexgc growth 5Y4.04%
ROICexc growth 3Y9.9%
ROICexc growth 5Y4.98%
OM growth 3Y7.37%
OM growth 5Y4.91%
PM growth 3Y-9.72%
PM growth 5Y-5.61%
GM growth 3Y3.45%
GM growth 5Y2.09%
F-Score4
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 6.58
Debt/EBITDA 1.69
Cap/Depr 151.95%
Cap/Sales 5.39%
Interest Coverage 12.22
Cash Conversion 52.22%
Profit Quality 28.65%
Current Ratio 1.33
Quick Ratio 1.11
Altman-Z 1.36
F-Score4
WACC3.22%
ROIC/WACC1.41
Cap/Depr(3y)148.32%
Cap/Depr(5y)138.32%
Cap/Sales(3y)5.18%
Cap/Sales(5y)5.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.97%
EPS 3Y21.97%
EPS 5Y17.78%
EPS Q2Q%33.51%
EPS Next Y-0.33%
EPS Next 2Y0.31%
EPS Next 3Y1.09%
EPS Next 5Y2.26%
Revenue 1Y (TTM)0.6%
Revenue growth 3Y10.38%
Revenue growth 5Y7.84%
Sales Q2Q%2.13%
Revenue Next Year0.8%
Revenue Next 2Y0.19%
Revenue Next 3Y1.32%
Revenue Next 5Y4.89%
EBIT growth 1Y15.71%
EBIT growth 3Y18.52%
EBIT growth 5Y13.14%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-28.02%
FCF growth 3Y-23.7%
FCF growth 5Y-12.55%
OCF growth 1Y-12.66%
OCF growth 3Y-8.11%
OCF growth 5Y-4.59%

BERKSHIRE HATHAWAY INC-CL B / BRYN.DE Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for BERKSHIRE HATHAWAY INC-CL B?

ChartMill assigns a fundamental rating of 5 / 10 to BRYN.DE.


What is the valuation status of BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) stock?

ChartMill assigns a valuation rating of 8 / 10 to BERKSHIRE HATHAWAY INC-CL B (BRYN.DE). This can be considered as Undervalued.


What is the profitability of BRYN stock?

BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) has a profitability rating of 6 / 10.


What are the PE and PB ratios of BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) stock?

The Price/Earnings (PE) ratio for BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) is 0.01 and the Price/Book (PB) ratio is 0.


How financially healthy is BERKSHIRE HATHAWAY INC-CL B?

The financial health rating of BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) is 5 / 10.